Navigation Links
US Senate Votes against Testing of Pesticide on Humans

The US congress is considering whether to temporarily ban the Environmental Protection Agency (EPA) from using human tests to determine whether a pesticide should be marketed//. Lawmakers on Capitol Hill will soon decide whether to place a one year moratorium on the conduct and use of studies that expose participants to pesticides. In most cases, trials are conducted by companies seeking to have their pesticides approved by the agency for marketing.

The Republican controlled US senate voted 60 to 37 to enact, such a moratorium, in an amendment to the spending bill that funds the EPA. The amendment would prohibit the agency, beginning on 1 October, from conducting human exposure tests or using data from tests conducted by third parties in its pesticide risk assessments. An identical amendment was passed by the House in May.

The Pesticide companies became interested in human testing seemingly in a bid to circumvent a 1996 law that made it more difficult to use animal tests to meet agency standards for protecting vulnerable populations such as children from pesticide residues. The EPA now considers human testing data on a case by case basis, rejecting only experiments deemed scientifically unsound or ‘fundamentally unethical’ by EPA staff.

“The moral and ethical issues surrounding these pesticide experiments are overwhelming,” California Democratic Senator Barbara Boxer, who introduced the amendment, said after the vote. The Pesticide industry, represented by the Washington lobbying group CropLife America, adds that it is ‘troubled by the blatant manipulation of the facts’ by Democratic senators. “Sound science and public health protections have affirmed the safety and ethics of human data studies,’ the group said in its statement.

An alternative amendment, sponsored by Republican Senator Conrad Burns, also passed the senate by a vote of 57 to 40. That version would allow the EPA to use third party human tests in licensin g decisions, within careful constraints. Unlike the Boxer amendment, it does not prohibit the EPA from conducting its own tests. A joint House Senate committee is expected this summer to determine which version prevails.

(Source: Nature Medcine)
'"/>




Related medicine news :

1. Senate assures ban on smoking
2. US Senate Approves Embryo-research Plan Despite Presidents Refusal
3. Senate Committee Approves Telemedicine Mental Health Bill
4. US Senate Passes Stem Cell Research Bill
5. Multi billion-dollar suit filed against cell phone firm for causing brain tumours
6. Man against HIV – new vaccine ready for human trials
7. Antibiotics losing their power against acne
8. South Africa Wins landmark case against pharmaceutical giants
9. Vitamin E, the latest warrior against diabetes
10. Acne may protect against infections
11. Fight against E.coli
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/22/2017)... ... February 22, 2017 , ... When it came time to ... in Georgia, PENETRON Specialty Products (PSP) provided the solution. January’s grand opening presented ... $51 million to purchase and renovate the 185,000 square-foot office complex, which was ...
(Date:2/22/2017)... Raton, FL (PRWEB) , ... February 22, 2017 , ... ... primarily from deer antler velvet, announced its products are coming soon to Amazon.com, the ... Clint and Shelley Thomson as a means to develop an effective natural treatment for ...
(Date:2/22/2017)... ... February 22, 2017 , ... The Waismann Method® is providing a ... have recently fallen victim to America’s opioid epidemic. Now, opiate dependent individuals can be ... are free from the shame, stigma, and harmful labeling believed to prevent ...
(Date:2/22/2017)... ... February 22, 2017 , ... The National Academy of Certified ... the April 2017 testing period. NACCM, a nonprofit organization, has provided the premier ... exam is periodically re-calibrated to ensure that newly certified professionals are prepared to ...
(Date:2/22/2017)... ... February 22, 2017 , ... Giving patients with diabetes ... emergency room, fewer hospital admissions, and better blood pressure and glycemic control, a ... The study can be found here . , The study comes as ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... CAMBRIDGE, England and DEERFIELD, Ill. ... U.S.A. , Inc., a wholly-owned subsidiary ... Limited, a joint venture between Cambridge Cognition Holdings PLC ... the use of a specially designed app on an ... in patients with Major Depressive Disorder (MDD). ...
(Date:2/23/2017)...  CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: ... fourth quarter and full year 2016 financial results on Thursday, ... financial markets. Following the announcement, members of the management ... the results and provide a general corporate update at 4:30 ... be obtained as follows: Thursday, March 2 ...
(Date:2/22/2017)... Feb. 22, 2017  Andre, DiMino, CEO of ADM ... manufacturer of innovative technologies and products, commented on ADMT,s ... February 21, 2017 in the Company,s quarterly report on ... ADMT CEO Andre, DiMino stated "During the quarter ended ... by devoting a larger portion of our engineering efforts ...
Breaking Medicine Technology: